DGX
Quest Diagnostics Incorporated · Healthcare · Medical - Diagnostics & Research
Momentum-Eingaben (vergleichbare Manager):
Halterbreite +15.4% ·
Aktienfluss -3.1% ·
neue Nettopositionen +13.3%
— Formel
Eigentümerfragmentierung — mehr Halter, kleinere Gesamtbeteiligung
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q1 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 154 | +1 | 78.04M | $16.53B | +7 | −6 |
| Q1 2026 | 156 | -1 | 76.50M | $14.98B | +4 | −6 |
| Q4 2025 | 156 | +4 | 87.42M | $15.15B | +5 | — |
| Q3 2025 | 16 | -1 | 54.97M | $10.47B | — | −2 |
| Q2 2025 | 15 | -3 | 44.54M | $8.00B | — | −3 |
| Q1 2025 | 15 | +2 | 17.80M | $3.01B | +3 | −1 |
| Q4 2024 | 13 | -2 | 18.37M | $2.77B | — | −2 |
| Q3 2024 | 14 | -1 | 12.70M | $1.97B | — | −1 |
| Q2 2024 | 15 | — | 9.75M | $1.33B | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 5.98M | +9.0% | $1.01B | 0.1% | ▲ Add | 4 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 5.98M | +9.0% | $1.01B | 0.1% | ▲ Add | 4 | SEC ↗ |
| 3 | State Street Global Advisors ✦ (passiv) | 5.18M | -0.8% | $875.92M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passiv) | 2.77M | +3.1% | $467.86M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passiv) | 2.77M | +3.1% | $467.86M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Wellington Management ✦ | 1.76M | -1.4% | $297.50M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 7 | Wellington Management ✦ | 1.76M | -1.4% | $297.50M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 8 | Wellington Management ✦ | 1.76M | -1.4% | $297.50M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 9 | Wellington Management ✦ | 1.76M | -1.4% | $297.50M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 10 | Wellington Management ✦ | 1.76M | -1.4% | $297.50M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 11 | Wellington Management ✦ | 1.76M | -1.4% | $297.50M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 12 | Norges Bank ✦ (passiv) | 1.29M | +1.4% | $218.17M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 13 | Marshall Wace ✦ | 483.29K | -39.3% | $81.77M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 14 | Marshall Wace ✦ | 483.29K | -39.3% | $81.77M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 136.04K | Neu | $23.02M | 0.0% | New | 1 | SEC ↗ |
| 16 | Adage Capital Partners ✦ | 72.62K | -62.6% | $12.29M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 54.65K | -62.7% | $9.25M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 54.65K | -62.7% | $9.25M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 54.65K | -62.7% | $9.25M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 54.65K | -62.7% | $9.25M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 21 | Bridgewater Associates ✦ | 29.27K | +33.7% | $4.95M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 22 | Millennium Management ✦ | 15.28K | -97.7% | $2.58M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 23 | Two Sigma Investments ✦ | 10.54K | -51.9% | $1.78M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 24 | Gotham Asset Management ✦ | 9.28K | +592.3% | $1.57M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 25 | Arrowstreet Capital ✦ | 7.96K | Neu | $1.35M | 0.0% | New | 1 | SEC ↗ |
| 26 | Fisher Asset Management ✦ | 2.35K | Neu | $397,388 | 0.0% | New | 1 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Citadel Advisors | $23.02M | 0.0% |
| Arrowstreet Capital | $1.35M | 0.0% |
| Fisher Asset Management | $397,388 | 0.0% |
Ausgestiegen
| D. E. Shaw & Co. | $11.97M | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 1 Inhaber, 41.40K Anteile, $8,113 gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.